The AI in Genomics Market has emerged as one of the most transformative segments within the modern biotechnology and data-driven healthcare landscape. AI in Genomics Market Size was estimated at 14.22 USD Billion in 2024. The AI in Genomics industry is projected to grow from 16.76 USD Billion in 2025 to 86.85 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 17.88 during the forecast period 2025 – 2035.
Global Artificial Intelligence (AI) in Genomics Market 2023 – Key Insights
- Reviews the current market landscape, including production capabilities, pricing structure, consumption patterns, and past performance indicators.
- Identifies major segments and sub-segments, showcasing the structural framework of the market.
- Includes historical market data from 2016 to 2023, along with forecasts extending to 2030, with breakdowns by company, product type, end-user industry, and major countries.
- Analyses growth patterns, market outlook, and the overall contribution of AI in genomics to the broader biotechnology space.
- Highlights major competitive developments, such as partnerships, product launches, collaborations, and acquisitions shaping the market.
- Provides a comprehensive assessment of key industry players, including sales volume, revenue contributions, SWOT analysis, and future development strategies.
As genomics becomes an integral part of precision medicine, AI-powered tools offer unprecedented accuracy in identifying genetic markers, predicting disease risks, and supporting advanced therapeutic development. The industry’s expansion is driven by the growing adoption of next-generation sequencing (NGS), increased investments in computational biology, and the rising demand for faster, more accurate genomic testing systems.
AI in Genomics Market Key Players
- Illumina (US)
- Thermo Fisher Scientific (US)
- Bristol-Myers Squibb (US)
- Regeneron Pharmaceuticals (US)
- GRAIL (US)
- Freenome (US)
- Zymergen (US)
- BenevolentAI (GB)
- Genomatix (DE)
Request To Free Sample of This Strategic Report:
https://www.marketresearchfuture.com/sample_request/31278
Segmentation Analysis
- By Intended Parent Type
Although the categories listed resemble those used in population-based or social studies, they highlight the diversity of end-users influencing data representation and sample sourcing. AI-powered genomic tools help analyze genetic information across infertile couples, single individuals, and LGBTQ+ couples, thereby supporting advanced reproductive genomics, risk evaluations, and personalized genetic counseling services.
- By Abdominal Aortic Aneurysm Type
In this context, data segmentation reflects different genomic conditions and research directions. Traditional and Gestational Abdominal Aortic Aneurysm insights leverage AI algorithms to detect hereditary vascular patterns, rare mutations, and risk predictors. AI systems are increasingly being deployed to interpret multi-omic datasets associated with vascular disorders, enabling precise early-stage interventions.
- By Compensation Type
AI applications also vary when observing genomics within regulatory or structural scenarios, such as altruistic vs. commercial frameworks. These categories highlight how genomic datasets are collected, processed, or compensated for in research studies. AI ensures that large-scale population data remains compliant, ethical, and reliable while offering enhanced accuracy for predictive modeling.
- By Abdominal Aortic Aneurysm Arrangement
The genomic ecosystem includes environments that are either independent research-driven or agency-assisted, reflecting how genomic data collaborations and decentralized testing facilities operate. AI tools support both formats by offering scalable platforms, automated workflows, and interoperability across laboratories worldwide.
- By Legal Framework
The permissive vs. restrictive legal landscape greatly influences genomic research and AI adoption. Countries with supportive regulations encourage innovation in predictive genomics, precision therapy design, and bioinformatics solutions. AI technology helps ensure compliance with ethical guidelines while providing enhanced genomic insights under varying legal systems.
Market Overview & Secondary Aspects (Size, Share, Growth, Trends)
The AI in Genomics Market has been witnessing substantial growth due to the increasing availability of large genomic datasets and the need for high-throughput analytical solutions. Market size has expanded steadily as AI tools enable researchers to decode complex genetic sequences at unmatched speed. Market share is highly influenced by the rapid integration of AI-driven genomics platforms across hospitals, diagnostic labs, biotech firms, and research organizations. Growth momentum is attributed to advancements in cloud computing, algorithmic modeling, and computational efficiency.
In addition, the increasing prevalence of chronic diseases and genetic disorders has further accelerated the utility of AI-enabled genomic diagnostics. Trends such as automated genetic testing, genome-wide association studies (GWAS), and digital phenotyping have broadened the market’s technological landscape. Emerging opportunities lie in personalized medicine programs, pharmacogenomics, and AI-driven biomarker discovery, creating strong revenue prospects across regions.
You Can Purchase Complete Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=31278
Regional Insights
North America
North America leads the global market, powered by strong technological infrastructure, high R&D investments, and early adoption of AI-enabled genomic sequencing tools. Major biotech hubs and AI startups contribute significantly to market expansion.
Europe
Europe exhibits strong growth due to government-funded genomics initiatives, regulatory harmonization, and widespread implementation of genomic medicine across healthcare systems.
Asia Pacific
Asia Pacific is one of the fastest-growing regions, driven by a rising population base, increasing prevalence of genetic disorders, and strong investments in AI-based biotechnology research.
South America
Growth is moderate, supported by expanding diagnostic capabilities, academic research collaborations, and rising awareness regarding genomics-based healthcare.
Middle East & Africa
MEA is gradually adopting AI in genomics, especially in precision medicine, rare disease diagnosis, and national genomic databases.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.marketresearchfuture.com/reports/ai-genomics-market-31278
Artificial Intelligence (AI) in Genomics Market – Enhanced Overview
The Artificial Intelligence (AI) in Genomics Market is becoming a powerful driver in modern healthcare and biotechnology. AI-enabled genomic solutions are transforming disease diagnosis, personalized medicine, and drug discovery by delivering more accurate, faster, and data-driven insights. This report provides an in-depth understanding of the sector, covering essential market dynamics, competitive landscape, technological advancements, and regional performance patterns.
What Makes the Information Worth Buying?
- Provides a comprehensive and detailed overview of the global Artificial Intelligence (AI) in Genomics Market, covering exchange patterns, applications, and geographical distribution.
- Offers insights into industry drivers, restraints, and rewards that influence market performance and growth potential.
- Helps businesses develop strategic approaches for tapping emerging market opportunities.
- Evaluates competitive and free-market structures, guiding the creation of effective business strategies.
Key Stakeholders
- AI Technology Providers (algorithm developers, cloud AI platforms)
- Genomics Companies (sequencing firms, bioinformatics providers)
- Pharmaceutical & Biotechnology Firms
- Research Institutes & Academic Centers
- Healthcare Providers & Clinical Laboratories
- Government & Regulatory Bodies
- Investors & Venture Capital Firms
- Data Analytics & Software Developers
Outlook for the Artificial Intelligence (AI) in Genomics Market
The future outlook remains strong, driven by increasing investments in precision medicine, rapid advances in machine learning technologies, and the growing demand for efficient genomic data interpretation. The integration of AI with next-generation sequencing is expected to accelerate discoveries in disease biomarkers, predictive diagnostics, and personalized therapies. Expanding regulatory support and rising industry collaborations further enhance global market potential.
Reasons to Buy the Report (Points)
- Gain deep insights into current and future market scenarios, enabling informed decision-making.
- Understand key trends, technological innovations, and growth opportunities across regions.
- Access a thorough competitive analysis to benchmark performance against top industry players.
- Benefit from segmentation-based insights for targeted planning and product positioning.
- Utilize historical and forecast data to support long-term strategic planning.
- Identify emerging opportunities and market gaps that can influence investment decisions.
- Strengthen business strategies with reliable SWOT analysis and market risk assessments.
